Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price: ₹273.10
Market cap: ₹3,058 Cr
Revenue (annual): ₹745.8 Cr
Net profit (annual): ₹168.7 Cr
P/E (TTM): 18.4×Sector 47.4×
Promoter holding: 43.24%-0.02% QoQ
FII holding: 26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Aug 2026 13:25 IST BSE

Advanced Enzyme Technologies Q1 FY27 Results: Net Profit ₹38.6 Cr, Down 4.5% YoY

Advanced Enzyme Technologies Ltd reported revenue from operations of ₹189.8 Cr (+2.1% YoY) and net profit of ₹38.6 Cr (-4.5% YoY) for Q1 FY27.

Key figure: Net profit ₹38.6 Cr · -4.5% YoY

Open full results → Read the filing ↗

9 May 2026 13:40 IST NSE

Financial ResultsAlfa Alert

Advanced Enzyme Technologies Q4 FY26 Results: Net Profit ₹45.3 Cr, Up 69.7% YoY

Advanced Enzyme Technologies Ltd reported revenue from operations of ₹203.4 Cr (+21.7% YoY) and net profit of ₹45.3 Cr (+69.7% YoY) for Q4 FY26.

Key figure: Net profit ₹45.3 Cr · +69.7% YoY

Open full results → Read the filing ↗

9 May 2026 13:39 IST NSE

Financial Results

Advanced Enzyme Technologies Financial Results

Advanced Enzyme Technologies reported FY26 annual results and recommended a ₹1.35 per share final dividend. The board also approved director re-appointments and auditor extensions.

Value: ₹0.13 Cr

Read the filing ↗